Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TNDM | Common Stock | Options Exercise | $59K | +6.56K | +346.72% | $9.00 | 8.45K | May 17, 2022 | Direct | F1 |
transaction | TNDM | Common Stock | Options Exercise | $0 | +2.21K | +26.09% | $0.00 | 10.7K | May 18, 2022 | Direct | |
transaction | TNDM | Common Stock | Options Exercise | $1M | +13.6K | +6.7% | $73.73 | 216K | May 17, 2022 | See Footnote | F2, F3 |
transaction | TNDM | Common Stock | Sale | -$1M | -10.8K | -4.98% | $92.91 | 205K | May 17, 2022 | See Footnote | F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TNDM | Stock Option | Options Exercise | $59K | +6.56K | $9.00 | 0 | May 17, 2022 | Common Stock | 6.56K | $9.00 | Direct | F4, F5 | |
transaction | TNDM | Warrant | Options Exercise | $1M | +13.6K | $73.73 | 0 | May 17, 2022 | Common Stock | 13.6K | $73.73 | See Footnote | F3, F6 | |
transaction | TNDM | Restricted Stock Unit | Options Exercise | $0 | +2.21K | $0.00* | 0 | May 18, 2022 | Common Stock | 2.21K | Direct | F7, F8, F9 |
Id | Content |
---|---|
F1 | Represents shares of common stock received upon exercise of a stock option award. |
F2 | The transaction reflects the cashless exercise of warrants to purchase common stock, at an exercise price of $73.726. Pursuant to the terms of the warrant, the shares of common stock were sold at a price equal to the average of the closing prices of the shares over the 30-day period ending three days prior to the date on which the notice of exercise was received by the Issuer. |
F3 | The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010. |
F4 | The options vested as to twenty-five percent (25%) of the underlying shares on 5/17/2018, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). |
F5 | The expiration date for these options is 10 years from the date of grant. |
F6 | The expiration dates for these warrants are May 25, 2022 (2,712 shares), and July 3, 2022 (10,850 shares). |
F7 | Awarded on May 18, 2021 pursuant to the 2013 Plan, as amended, and the agreements related thereto. |
F8 | Each restricted stock (RSU) unit represents a contingent right to receive one share of common stock of the Company. |
F9 | Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan. |